Advertisements



Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Valeritas V-Go demonstrates benefits compared to MDI therapy for type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

6 simple, science-backed ways to get rid of belly fat

Shutterstock/ nd3000  Having lots of fat in the abdominal area is strongly linked to diseases like type 2 diabetes and heart disease. Excess sugar and carb consumptio.....»»

Category: topSource: businessinsiderApr 12th, 2018

Coffee May Well Reduce the Risk of Type 2 Diabetes

Coffee May Well Reduce the Risk of Type 2 Diabetes A meta-analysis of 30 studies involving more than 10 years of research suggests coffee consumption may cut the risk of developing Ty.....»»

Category: topSource: livetradingnewsNov 28th, 2018

WellCare partners with diabetes-management startup

WellCare of New York has agreed to use Fit4D, a Manhattan-based company that helps people manage their type 2 diabetes. Fit4D offers a team of certified diabetes educators who can connect with... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkNov 26th, 2018

Coffee May Well Reduce the Risk of Type 2Diabetes

Coffee May Well Reduce the Risk of Type 2 Diabetes A meta-analysis of 30 studies involving more than 10 years of research suggests coffee consumption may cut the risk of developing T.....»»

Category: topSource: livetradingnewsNov 26th, 2018

Zafgen"s IND for diabetes treatment placed on hold by FDA

Zafgen Inc. said Monday the Food and Drug Administration ha placed a clinical hold on its investigational new drug application (IND) for the biopharmaceutical company's first U.S. clinical trial of its type 2 .....»»

Category: topSource: marketwatchNov 26th, 2018

Jury tells Aetna to pay $25M to late cancer patient"s family

A jury has ordered Aetna to pay more than $25 million to the family of an Oklahoma City woman who died a year after the insurance company refused to cover a type of radiation therapy......»»

Category: topSource: foxnewsNov 10th, 2018

The Keto Diet Fights: Obesity, Diabetes, Heart Disease and Alzheimer’s

The Keto Diet Fights: Obesity, Diabetes, Heart Disease and Alzheimer’s The 1 diet is being praised by leading health experts as an effective tool in battling the epidemics of obesity, diabetes, and heart disease......»»

Category: topSource: livetradingnewsNov 5th, 2018

The Real Danger of Diabetes

The Real Danger of Diabetes The increased risk of health conditions like cardiovascular disease, cancer and kidney disorders have been linked with diabetes and early death, a new stud.....»»

Category: topSource: livetradingnewsOct 17th, 2018

Stem cell research is paying off for New York

Most of us, at least once in our lives, are faced with a loved one diagnosed with cancer, diabetes, heart disease, sickle cell or another disease for which there is no cure. Twenty years ago, a... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkOct 10th, 2018

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes.....»»

Category: topSource: seekingalphaOct 5th, 2018

Eli Lilly"s Ultra Rapid Lispro Succeeds in Diabetes Studies

Eli Lilly's (LLY) insulin candidate, Ultra Rapid Lispro, meets primary endpoint of two late- stage studies in type I and type II diabetes patients of non-infer.....»»

Category: dealsSource: nytOct 3rd, 2018

Novo Nordisk: Type 1 Diabetes Treatments To Boost Growth

Novo Nordisk: Type 1 Diabetes Treatments To Boost Growth.....»»

Category: topSource: seekingalphaOct 1st, 2018

Alnylam stock drops 2.6% premarket on preliminary results for rare disease therapy

Alnylam Pharmaceuticals Inc. shares dropped 2.6% in Thursday premarket trade after the company released early results from a phase 3 trial fo.....»»

Category: topSource: marketwatchSep 27th, 2018

Nationwide Children"s gene therapy spinoff acquired for $100M

Yet another gene therapy spinoff from Nationwide Children's Hospital has been acquired for $100 million. Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of spee.....»»

Category: topSource: bizjournalsSep 21st, 2018

Many Americans With Diabetes Do Not Know It

Many Americans With Diabetes Do Not Know It It’s estimated more than 30% of American adults with diabetes don’t realize they are suffering from this potentially deadly disease. Data from the National Health.....»»

Category: topSource: livetradingnewsSep 20th, 2018

BioCryst stock surges 6% premarket after winning $35 million CDC contract for flu therapy

BioCryst Pharmaceuticals Inc. shares surged more than 6% premarket on the news that it has won a $35 million, five-year contract from the Centers for Disease Control and Prevention for up to 50,000 doses of its antiviral flu t.....»»

Category: topSource: marketwatchSep 6th, 2018

Novo Nordisk"s Ozempic Lowers Risk of Cardiovascular Events (revised)

Novo Nordisk (NVO) announces post hoc results from SUSTAIN 6 study demonstrating that Ozempic consistently reduces the risk of major cardiovascular (CV) events across type II diabetes population. Novo Nordisk A/S NVO announce.....»»

Category: worldSource: nytSep 4th, 2018

Pfizer stops developing therapy for the rare disease Duchenne muscular dystrophy

Pfizer Inc. is ending ongoing research for a Duchenne muscular dystrophy drug after finding that the evidence "did not support a significant treatment effect," the company said on Thursday. Shares slumped 0.5% premarket, while shares of DMD drugmaker S.....»»

Category: topSource: marketwatchAug 30th, 2018

Regenxbio expands pipeline with RGX-181 gene therapy for Batten disease

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 30th, 2018